MORGAN STANLEY PLC/CALL/MERCK & CO./160/0.1/20.12.24 Share Price

Warrant

DE000MB0CZW9

Real-time Bid/Ask 14:04:12 17/05/2024 BST
0.101 EUR / 0.125 EUR +7.62% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./160/0.1/20.12.24
Current month-19.85%
1 month-17.97%
Date Price Change
17/05/24 0.108 +2.86%
16/05/24 0.105 -7.89%
15/05/24 0.114 +17.53%
14/05/24 0.097 -3.00%
13/05/24 0.1 -11.50%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 09:12 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB0CZW
ISINDE000MB0CZW9
Date issued 09/11/2022
Strike 160 $
Maturity 20/12/2024 (217 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.48
Lowest since issue 0.019
Spread 0.032
Spread %24.06%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.9 USD
Average target price
141.6 USD
Spread / Average Target
+8.22%
Consensus